Bibliography: Interventions – Treatment

Discover what works (and what doesn’t work) in the areas of drug prevention, treatment, harm reduction and social reintegration (EMCDDA)

This is the report on the Recovery Partnership review of the current state of alcohol treatment in England

Dose-capping – limiting the amount of methadone a patient can take on a daily basis – was ruled “contrary to the current state of the medical literature and the principle of individualized treatment” in 2007 by SAMHSA in the Federal Guidelines for Opioid Treatment. So it’s surprising that it still goes on (ATF)

The report presents national and jurisdictional data from the Australian Needle and Syringe Program Survey from 1995 to 2014. Around two thirds of Australia’s primary Needle and Syringe Program services participate in the survey and program attendees have participated on more than 45,000 occasions (The Kirby Institute, UNSW Australia)

The paper addresses a range of issues including prevention and treatment issues (Irish Medical Organisation)

As we describe below, available evidence shows that the misuse of benzodiazepines contributes to morbidity and mortality among high-risk opioid users (EMCDDA)

This review outlines policy recommendations made in the 2014 World Health Organisation (WHO) Guidelines on Screening, Care and Treatment of HCV and their relevance to PWID (Drug Policy)

Continuation of methadone maintenance during incarceration could contribute to greater treatment engagement after release, which could in turn reduce the risk of death from overdose and risk behaviours (The Lancet)

Women and girls who inject drugs are more likely than their male counterparts to acquire HIV. In addition to criminalization, punitive laws, and social stigma that puts all injecting drug users at increased risk, women are made even more vulnerable by social, economic, and culturally embedded power imbalances (JAIDS)

This report reviews the impact of the Forum during 2014 and looks ahead by setting out recommendations that seek to reduce the numbers at risk (SFAD)

This research and policy briefing reminds us of a few key findings from RAPt’s research and experience (RAPT)

This research and policy briefing describes the worrying extent of mental health problems amongst prisoners, and the close correlation between mental health conditions such as depression and post traumatic stress disorders, and substance misuse (RAPT)

This fourth NTI report provides 2012–2013 fiscal-year data from six provinces, one territory and one provincial association and has expanded its scope to include information on the primary substance for which treatment was sought. The report also includes information on the total number of hospital stays related to substance use disorders and their associated costs. (CCSA)

A total of 573 forms were completed and entered directly online or subsequently entered by the research team at Turning Point (Turning Point,)

The first known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care has been conducted by researchers who found that patients given the medication buprenorphine were more likely to engage in addiction treatment and reduce their illicit opioid use (Science Daily)

Subgroup Analyses of a Heterogeneous Sample of Service Users (JMIR)

Following are highlights from the Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS NMDS). Further information will be released in June 2015 (AIHW)

Highlights from the NOPSAD collection (AIHW)

The past five years has seen an unprecedented increase in the number of these psychoactive drugs (BMJ)

The program, launched in 2011 as the first of its kind in the country, allows law enforcement officers to direct people charged with low-level drug or sex work offenses into community-based services instead of prosecution and jail (Open Society Foundations)

When 80 per cent of your clients have a dual diagnosis, asking whether the service needs a dual diagnosis worker is getting things the wrong way around (Advances in Dual Diagnosis)

Cohort studies of dependent users in treatment, and people who inject drugs (NDARC)

Politicians may not like it, but evidence shows that giving heroin to some users reduces harm, argues Martin T Schechter (BMJ)

Lessons from a roundtable of commissioners (DrugScope)

This briefing describes several aims (DrugScope)

Prohibition had negative outcomes for the millions of individuals who find it worthwhile to use psychedelics in various cultural settings outside of those in the clinic (Lancet)

This is the second in a series of briefing papers by DrugScope on behalf of the Recovery Partnership which examine some of the broader issues around recovery from substance misuse problems. The briefing has a regional focus on South East England (DrugScope)

Public Health England (PHE) has announced the successful applicants for £10 million of capital funding for services that are helping people in England with drug or alcohol problems to recover from their addiction. Over 50 projects across England, in partnership with local authorities, will receive grants from PHE